EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunotherapy in Glioblastoma: Why promising strategies fail to improve survival

Osama Salar, Mehar Masroor, Kanchan Chaudhary, Muhammad Shahzad Shamim

Journal of the Pakistan Medical Association · 2026

DOI: 10.47391/jpma.26-74 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the Pakistan Medical Association, 2026. Verfasst von Osama Salar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Frontier Medical and Dental College, Abbottabad. Hauptthemen laut MEDLINE: Glioblastoma, Immunotherapy, Brain Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has transformed the management of several extracranial malignancies; however, its efficacy in GBM has been limited. Large clinical trials evaluating immune checkpoint inhibitors have failed to demonstrate meaningful survival benefit in newly diagnosed and recurrent GBM. Other modalities, including dendritic cell vaccines, chimeric antigen receptor (CAR) T-cell therapies, and oncolytic virotherapy, have shown encouraging but modest results in selected patients. This narrative review summarizes the current role of immunotherapy in GBM, focussing on its impact on patient outcomes, underlying barriers to therapeutic success, and future directions. Keywords: Glioblastoma; Immunotherapy; Oncolytic virotherapy; Dendritic cell vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaImmunotherapyBrain NeoplasmsHumansDendritic CellsCancer VaccinesOncolytic VirotherapyImmune Checkpoint InhibitorsImmunotherapy, Adoptive

Stichwörter der Autor:innen

Glioblastoma; Immunotherapy; Oncolytic virotherapy; Dendritic cell vaccine.

Substanzen

Cancer VaccinesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Medical College, Frontier Medical and Dental College, Abbottabad.
  • Department of Surgery, Aga Khan University Hospital, Karachi.
  • Medical College, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan.

Zitieren

APA

Salar, O., Masroor, M., Chaudhary, K., & Shamim, M. S. (2026). Immunotherapy in Glioblastoma: Why promising strategies fail to improve survival. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.26-74

Vancouver

Salar O, Masroor M, Chaudhary K, Shamim MS. Immunotherapy in Glioblastoma: Why promising strategies fail to improve survival. Journal of the Pakistan Medical Association. 2026. doi:10.47391/jpma.26-74

BibTeX
@article{Salar2026,
  author = {Salar, Osama and Masroor, Mehar and Chaudhary, Kanchan and Shamim, Muhammad Shahzad},
  title = {Immunotherapy in Glioblastoma: Why promising strategies fail to improve survival},
  journal = {Journal of the Pakistan Medical Association},
  year = {2026},
  doi = {10.47391/jpma.26-74}
}
Kostenlos starten →